Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Running, J. A.
Right arrow Articles by Berry, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Running, J. A.
Right arrow Articles by Berry, A.
Agricola
Right arrow Articles by Running, J. A.
Right arrow Articles by Berry, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Experimental Botany, Vol. 54, No. 389, pp. 1841-1849, August 1, 2003
© 2003 Oxford University Press

The pathway of L-ascorbic acid biosynthesis in the colourless microalga Prototheca moriformis

Received 11 February 2003; Accepted 2 May 2003

Jeffrey Allan Running*,, Richard Paul Burlingame{dagger}, and Alan Berry{ddagger},

Bio-Technical Resources, 1035 South 7th Street, Manitowoc, WI 54220, USA

* To whom correspondence should be sent. Fax: +1 920 684 5519. E-mail:jeff{at}biotechresources.com
{dagger} Present address: Dyadic International Inc., 140 Intracoastal Pointe Drive, Suite 404, Jupiter, FL 33477-5094, USA.
{ddagger} Present address: Biotechnology Department, Research and Development, Roche Vitamins AG, CH-4070 Basel, Switzerland.
Abbreviations: AA, L-ascorbic acid; GMP, GDP-Mannose pyrophosphorylase; L-GalL, L-galactono-1,4-lactone; L-GalDH, L-galactose dehydrogenase; PMI, phosphomannose isomerase; PMM, phosphomannomutase.

When mutant strain UV77–247 of Prototheca moriformis Kruger was fed D-[1-13C]Glc, it synthesized L-ascorbic acid (AA) with approximately three-quarters of the label at the C-1 position and the remaining label at the C-6 position, showing that AA is made by a non-inversion (retention) pathway, i.e. C-1 of Glc becomes C-1 of AA. The label present at C-6 is consistent with the glycolytic conversion of Glc to 3-carbon intermediates and subsequent gluconeogenesis. Compounds suggested as intermediates in inversion-type pathways were not converted to AA. Most strains converted Man to AA at a rate greater than they did Glc. Enzyme activities leading from Fru-6-P to the formation of GDP-Man were identified in all strains, but none of these activities correlated with the mutants’ abilities to accumulate AA. However, there was a strong correlation between GDP-Man-3,5-epimerase activity and AA accumulation. Wild-type P. moriformis ATCC 75669 and mutant strains of varying AA-synthesizing abilities rapidly converted L-Gal or L-galactono-1,4-lactone to AA. Based on this data, a biosynthetic pathway from Glc to AA is proposed in which the epimerase is the rate-limiting activity in AA synthesis.

Key words: GDP-Mannose-3,5-epimerase, L-ascorbic acid, microalga, Prototheca.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.